Showing results (1941-1950 of 3,593) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|August 6, 2019
Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis BHuimin Fan, Luping Lin, Shijie Jia, et al.Journal of Viral Hepatitis|February 18, 2021
Reduction in hepatitis C-related hospitalizations after the implementation of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System: regional level differencesJuan José Vegas, Javier Flores-Herrera, Pello Latasa, et al.Journal of Viral Hepatitis|February 24, 2021
Hepatitis C related cognitive impairment: Impact of viral and host factors and response to therapyNir Bar, Sharon Levy, Liat Deutsch, et al.Journal of Viral Hepatitis|February 11, 2017
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapyK-S Cheung, W-K Seto, D K-H Wong, et al.Journal of Viral Hepatitis|March 2, 2017
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)A Aguilera, D Navarro, F Rodríguez-Frias, et al.Journal of Viral Hepatitis|March 9, 2017
Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United StatesK Young, B Liu, T Bhuket, et al.Journal of Viral Hepatitis|March 9, 2017
Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosisM Buti, R Domínguez-Hernández, I Oyagüez, et al.Journal of Viral Hepatitis|December 8, 2016
Interferon-free therapies for patients with chronic hepatitis C genotype 3 infection: A systematic reviewV Gimeno-Ballester, M Buti, R San Miguel, et al.Journal of Viral Hepatitis|December 10, 2016
Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in IndiaS R Shah, A Chowdhury, R Mehta, et al.Journal of Viral Hepatitis|March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C RegistryT M Welzel, H Hinrichsen, C Sarrazin, et al.Pageof 360